Douglas A. Michels

Douglas A. Michels, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Orasure Technologies Inc, West Pharmaceutical Services Inc and Tyme Technologies, Inc. Over a trading history stretching from 31 December 2005 to 6 May 2025, the count stands at 160 filings.

In open-market terms, that means 2 purchases worth €98k on one side and 25 sales worth €20.6M on the other. The net balance comes to €20.5M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 92 share grants and 25 option exercises.

On 8 May 2025 came the latest disclosure, a share grant in West Pharmaceutical Services Inc. The latest purchase dates back some time: it was published 2,257 days ago, on 3 September 2020. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.